Cite
MLA Citation
N. Jewel Samadder et al.. “S1331 Phase II Trial of Weekly Erlotinib Dosing to Reduce Duodenal Polyp Burden Associated With Familial Adenomatous Polyposis.” American journal of gastroenterology, vol. 116, n.d., p. S614. http://access.bl.uk/ark:/81055/vdc_100144524802.0x000026